Larsen B, Dorscheid E, Macher-Hanselmann F, Büch U
Klinik für Anästhesiologie und Intensivmedizin, Universitätskliniken des Saarlandes, Homburg/Saar.
Anaesthesist. 1998 Sep;47(9):741-6. doi: 10.1007/s001010050621.
Clonidine, an alpha 2-receptor agonist, has been reported to prolong the blocking actions of local anaesthetics. The aim of this study was to investigate the effects of spinally injected clonidine on the duration of spinal anaesthesia by mepivacaine and on the postoperative demand for analgesics.
Forty-five patients who had transurethral urological surgery under spinal anaesthesia were randomized to 3 groups (n = 15 each) and studied in a double-blind fashion. Group I received 80 mg mepivacaine 4% only, while in group II mepivacaine was combined with 75 micrograms clonidine intraspinally and in group III with 150 micrograms clonidine. Onset time, spread of anaesthesia, duration of sensory and motor blockade, regression of anaesthesia and postoperative demand for analgesics were recorded. In addition heart rate and mean arterial pressure were measured at regular intervals.
Clonidine had no effect on the onset time and spread or intensity of spinal anaesthesia. The higher dose of clonidine significantly prolonged the duration of sensory blockade by 50 min and the duration of motor block by 40 min, while 75 micrograms had no significant effect. Heart rate and mean arterial pressure were significantly reduced in both clonidine groups when compared to plain mepivacaine. There was no significant reduction in postoperative analgesic demand.
While clonidine prolonged sensory analgesia, there was also an undesirable prolongation of motor block postoperatively. In addition, there was a significant and long lasting reduction in heart rate and mean arterial pressure in both clonidine groups. Unfavourably, postoperative demand of analgesics was not reduced by spinal injection of clonidine. Thus, the routine addition of clonidine for spinal anaesthesia with local anaesthetics is not recommended.
可乐定是一种α2受体激动剂,据报道可延长局部麻醉药的阻滞作用。本研究的目的是探讨脊髓注射可乐定对甲哌卡因脊髓麻醉持续时间及术后镇痛需求的影响。
45例在脊髓麻醉下行经尿道泌尿外科手术的患者被随机分为3组(每组n = 15),采用双盲法进行研究。第一组仅接受4%的80mg甲哌卡因,第二组甲哌卡因与75μg可乐定脊髓内联合使用,第三组与150μg可乐定联合使用。记录起效时间、麻醉平面、感觉和运动阻滞持续时间、麻醉消退情况及术后镇痛需求。此外,定期测量心率和平均动脉压。
可乐定对脊髓麻醉的起效时间、平面扩散或强度无影响。较高剂量的可乐定显著延长感觉阻滞持续时间50分钟,运动阻滞持续时间40分钟,而75μg则无显著影响。与单纯甲哌卡因相比,两组可乐定组的心率和平均动脉压均显著降低。术后镇痛需求无显著减少。
虽然可乐定延长了感觉镇痛时间,但术后运动阻滞也出现了不良的延长。此外,两组可乐定组的心率和平均动脉压均有显著且持久的降低。不利的是,脊髓注射可乐定并未降低术后镇痛需求。因此,不建议在局部麻醉药脊髓麻醉中常规添加可乐定。